Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Caredx Inc (NQ: CDNA )

8.950 +0.120 (+1.36%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 706,618
Open 8.850
Bid (Size) 8.980 (1)
Ask (Size) 9.080 (7)
Prev. Close 8.830
Today's Range 8.720 - 8.990
52wk Range 8.100 - 40.42
Shares Outstanding 52,627,165
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
CareDx Presents Latest Advancements at 12th Congress of the International Pediatric Transplant Association
From CareDx, Inc.
Via Business Wire
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

YTD
-19.37%
-19.37%
1 Month
-36.12%
-36.12%
3 Month
-20.52%
-20.52%
6 Month
-44.51%
-44.51%
1 Year
-76.84%
-76.84%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
Via Benzinga
Analyst Expectations for CareDx's Future
Via Benzinga
CareDx Earns Stock Downgrade Amid CMS Coverage Cuts Change Thesis
Via Benzinga
CareDx's Return On Capital Employed Insights
Via Benzinga
The American Society of Transplant Surgeons Position Statement Supports Use of CareDx’s AlloSure Kidney for Organ Transplant Surveillance
From CareDx, Inc.
Via Business Wire
CareDx Update Regarding Raymond James & Associates’ Conference
From CareDx, Inc.
Via Business Wire
Kennedy-Wilson, Radian Group, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday
Via Benzinga
CareDx To Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference
From CareDx, Inc.
Via Business Wire
Earnings Outlook For CareDx
Via Benzinga
Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2023
Via Benzinga
CareDx Comments on MolDX Publication of New Billing and Coding Article
From CareDx, Inc.
Via Business Wire
CareDx Key Supporter of the National Kidney Foundation’s Annual Kidney Patient Summit
From CareDx, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Dentsply Sirona, Chico's FAS, Kontoor Brands And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Why Titan International Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
CareDx Reports Fourth Quarter and Full Year 2022 Results
From CareDx, Inc.
Via Business Wire
Earnings Scheduled For February 27, 2023
Via Benzinga
CareDx Showcases Clinical Value of Multimodality and AI Innovation at the American Society of Transplantation Cutting Edge of Transplantation Meeting
From CareDx, Inc.
Via Business Wire
CareDx to Report Fourth Quarter and Full Year 2022 Financial Results
From CareDx, Inc.
Via Business Wire
CareDx Showcases Latest Advancements in Cellular Transplant and Therapy Including Specialized Digital Health Solutions at the 2023 Tandem Meetings
From CareDx, Inc.
Via Business Wire
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA
From Kahn Swick & Foti, LLC
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.